Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

10x Genomics (TXG) Other Gross PP&E Adjustments (2018 - 2025)

10x Genomics' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $295.3 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 1.3% year-over-year to $295.3 million; the TTM value through Dec 2025 reached $295.3 million, up 1.3%, while the annual FY2025 figure was $295.3 million, 1.3% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $295.3 million at 10x Genomics, down from $314.7 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $323.8 million in Q3 2024 and bottomed at -$75.7 million in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $292.5 million (2023), against an average of $191.7 million.
  • The largest annual shift saw Other Gross PP&E Adjustments plummeted 190.35% in 2022 before it soared 535.6% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $145.3 million in 2021, then surged by 83.97% to $267.4 million in 2022, then grew by 9.72% to $293.4 million in 2023, then dropped by 0.62% to $291.6 million in 2024, then rose by 1.3% to $295.3 million in 2025.
  • Per Business Quant, the three most recent readings for TXG's Other Gross PP&E Adjustments are $295.3 million (Q4 2025), $314.7 million (Q3 2025), and $316.8 million (Q2 2025).